Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

This was the stock's second consecutive day of losses.

Fintel reports that on May 22, 2025, Citigroup downgraded their outlook for Becton, Dickinson and (NYSE:BDX) from Buy to ...

6 analysts have shared their evaluations of Becton Dickinson BDX during the recent three months, expressing a mix of bullish ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...

The stock's rise snapped a four-day losing streak.

In this article, we are going to take a look at where Becton, Dickinson, and Company (NYSE:BDX) stands against other best falling stocks to buy according to analysts. Over the past two years ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Citigroup on May 22, 2025. The analyst firm set a price target for $185.00 expecting BDX to rise to within 12 months (a ...

BECTON, DICKINSON ($BDX) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of $3.35 per share, beating estimates of $3.31 by $0.04 ...